Semaglutide (Ozempic/Wegovy): The Proven Performer Semaglutide was the medication that really put GLP-1 therapy on the map, and for good reason
While these side effects are often temporary and improve with time, stopping and restarting the medication can reduce its effectiveness
6 Windows of epigenetic plasticity to re-direct health trajectories to positive outcomes In summary, there appears to be a common denominator in the trajectories of stress-related disorders that we propose involves an epigenetic embedding of early life experiences through the mitochondrial metabolite LAC acting as part of a critical network system with other important mediators of brain plasticity and function, and that, when supplemented, rapidly alters gene expression profiles to ameliorate behaviors and cognitive function in animal models deficient in LAC because of stress-induced causes
Cancer Cancer is a disease of improper cellular replication
Discharging Never discharge Batteries at amperage rates higher than specified on Batteries labels
Researchers enrolled 17,604 adults who: were 45 years or older had overweight or obesity (BMI 27) already had heart disease (such as a prior heart attack, stroke, or peripheral artery disease) did not have diabetes Participants were randomly assigned to receive either: semaglutide 2.4 mg weekly, or a placebo (an injection with no active medication) They were followed for about 40 months (over 3 years)